

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectivel...
Q2 2026
Aug 13, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 26, 2026
Q4 2025
Mar 26, 2026
Q3 2025
Nov 13, 2025